Key Factor Supporting Veterinary Renal Disease Market Development in 2025: Increasing Pet Ownership Fuels Growth In The Veterinary Renal Disease Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Veterinary Renal Disease Market Size By 2025?
In recent times, the market size for veterinary renal disease has seen robust growth. It is forecasted to rise from a valuation of $15.5 billion in 2024 to approximately $16.63 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.3%. Factors contributing to the growth during the historic period include increasing initiatives for disease awareness, a change in consumer choices towards organic and natural pet food, a higher rate of pet ownership worldwide, adjustments in regulations pertaining to veterinary pharmaceuticals, and an increased focus on pet health and nutrition awareness.

How Big Is the Veterinary Renal Disease Market Size Expected to Grow by 2029?
Expectation is that the veterinary renal disease market will experience significant growth in the coming years, reaching $21.74 billion in 2029 with a compound annual growth rate (CAGR) of 6.9%. Factors motivating growth during the forecast period include the rise of personalized veterinary medicine, the broadening application of telemedicine and remote tracking in animal care, an increase in veterinary clinical trials, the use of blockchain for supply chain clarity in veterinary product distribution, and the utilization of AI and machine learning in animal diagnosis. Anticipated trends during the forecast period involve a growing demand for veterinary virtual consultations, a rise in bespoke pet nutrition programs, an increased usage of pet health monitoring wearables, the enlargement of veterinary telemedicine platforms, and the implementation of precision medicine in veterinary oncology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-renal-disease-global-market-report

Which Key Market Drivers Powering Veterinary Renal Disease Market Expansion and Growth?
The growth of the veterinary renal disease market is likely to be fueled by the rise in pet ownership. Veterinary renal disease, a term used to describe conditions that impair kidney function in animals, can lead to increased thirst, frequent urination, decreased appetite, and weight loss. Factors such as longer living pets, exposure to environmental toxins, particular dietary influences, and genetic predispositions all contribute to the rise in veterinary renal disease cases. Treatments typically include dietary management, medication, and fluid therapies to mitigate symptoms, slow the disease's progression, and enhance the animals' quality of life. For example, in October 2022, Cooper Pet Care, a mobile pet care platform based in the Netherlands, estimated that about 145 million pet animals would exist in the European Union, including Norway and Switzerland. This represents an increase of 5 million from 2021's approximate 140 million pets, which consist of about 66 million dogs and 79 million cats. Therefore, the surge in pet ownership contributes significantly to the expansion of the veterinary renal disease market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15957&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Veterinary Renal Disease Market?
Leading organizations within the veterinary renal disease market are making strides towards technical advancement in diagnosis and treatment by creating new diagnostic tests. These tests are capable of identifying kidney damage even when there aren't noticeable clinical signs. The objective is to detect initial changes in renal function or structure and instigate early intervention to avoid progressing to severe stages of renal dysfunction. IDEXX Laboratories Inc., an American company that produces and develops veterinary products and services, introduced the industry's first diagnostic test for kidney damage in cats and dogs in June 2023. Renamed the IDEXX Cystatin B Test, it is crafted to aid veterinarians in identifying kidney damage before any changes in kidney function are evident, thereby improving patient results. This IDEXX Cystatin B Test will become a part of test panels that examine renal health, offering critical insights during an estimated two million annual patient visits.

What Are the Emerging Segments in the Veterinary Renal Disease Market?
The veterinary renal disease market covered in this report is segmented -

1) By Type: Diagnosis, Treatment
2) By Animal Type: Canine, Feline, Bovine, Equine, Other Animal Types
3) By Indication: Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis, Other Indications
4) By Route of Administration: Injectable, Oral
5) By Distribution Channel: Pharmacies, Pet Specialty Stores, E-commerce, Other Distribution Channels

Subsegments:
1) By Diagnosis: Blood Tests, Urine Tests, Imaging, Biopsy
2) By Treatment: Medications, Dialysis, Kidney Transplantation, Fluid Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15957&type=smp

Who Are the Global Leaders in the Veterinary Renal Disease Market?
Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestlé Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Clinical Renal Associates, Veterinary Transplant Services Inc., Kibow Biotech Inc., Northwest Renal Clinic

Which are the Top Profitable Regional Markets for the Veterinary Renal Disease Industry?
North America was the largest region in the veterinary renal disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15957

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.